An interventional study of Electroacupuncture in Neuralgia, Neuralgia; Postherpetic and Diabetic Neuropathy, Painful, sponsored by Seoul National University. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-14.
Sponsored by Seoul National University · Not applicable, Interventional, and Treatment
Among 37 studies in Neuralgia with a site in Korea, Republic of — 1 open to participants now, 1 under way, none of them phase 3. Neuralgia · Korea, Republic of.
Among the 37 studies in Neuralgia with a site in Korea, Republic of, this one is the 30th largest by enrollment of the 34 interventional ones that give a count, is one of 5 that started in 2017, is one of 10 with no phase, and was the 20th registered.
1,100 studies on the registry are indexed under Neuralgia; 241 are open to participants now.
This study's enrollment of 22 is below the median of 52 across 831 interventional studies indexed under Neuralgia.
Browse Neuralgia studies →1 of the 37 studies in Neuralgia with a site in Korea, Republic of is open now.
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 152 Neuralgia studies recruiting now, 76 (50%) set no upper age limit and 44 (29%) stop at 75 or younger; 8 take children under 18; 12 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →37 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 5 started in 2017.
Median enrollment 90 across the 34 interventional studies, 312 across the 3 observational. Of the 25 that completed or were terminated, 7 (28%) have results posted.
18 of 37 have an industry lead sponsor. The 10 most frequent:
Seoul National University is the lead sponsor of 32 studies on the registry; 10 are open to participants now.
Seoul National University has 4 studies filed under Neuralgia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 37 studies in Neuralgia with a site in Korea, Republic of, from their registry updates:
Nothing recorded among them since 2026-09-25.
The investigators will evaluate the effectiveness and safety of acupuncture treatment in refractory neuropathic pain patients.
The purpose of this study was to evaluate the effectiveness of acupuncture treatment in the patients with the following neuropathic pain related syndrome.
Patients with refractory neuropathic pain who do not respond to conservative treatment for more than 3 months should be included. Acupuncture treatment is maintained for 2 months in oriental medicine hospital. The effect is evaluated through the numeric rating score and the validated questionnaire.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Electroacupunture for 2months
Procedure: Electroacupuncture
lectroacupuncture is a form of acupuncture where a small electric current is passed between pairs of acupuncture needles. According to some acupuncturists, this practice augments the use of regular acupuncture, can restore health and well-being, and is particularly good for treating pain.
Change from baseline Numeric rating scale pain score (0-10) at 4 weeks
The Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).
Time frame: At 4-week follow-up visit
Change from baseline Numeric rating scale pain score (0-10) at 8 weeks
The Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).
Time frame: At 8-week follow-up visit
Change from the score of the short-form McGill Pain Questionnaire at 8 weeks
The main component of the SF-MPQ consists of 15 descriptors (11 sensory; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe. Three pain scores are derived from the sum of the intensity rank values of the words chosen for sensory, affective and total descriptors. The SF-MPQ also includes the Present Pain Intensity (PPI) index of the standard MPQ and a visual analogue scale (VAS).
Time frame: At 8-week follow-up visit
Change from baseline score of Brief Pain Inventory Short Form (BFI-SF) at 8 weeks
The Brief Pain Inventory (BPI) rapidly assesses the severity of pain and its impact on functioning.
Time frame: At 8-week follow-up visit
Patients' Global Impression of Change (PGIC) scale
The self-report measure Patient Global Impression of Change (PGIC) reflects a patient's belief about the efficacy of treatment. 1=very much improved since the initiation of treatment; 2=much improved; 3=minimally improved; 4=no change from baseline (the initiation of treatment); 5=minimally worse; 6= much worse; 7=very much worse since the initiation of treatment.
Time frame: At 8-week follow-up visit
5-pointed patient satisfaction scale
The 5-pointed patient satisfaction scale is an 5-point scale for patient self-reporting of satisfaction with treatment. 1. Very satisfied 2. Satisfied 3. Neither satisfied nor dissatisfied 4. Dissatisfied 5. Very dissatisfied
Time frame: At 8-week follow-up visit
Plan to share: Undecided
Ran from May 2017 to primary completion in Feb 2018, 9 months.
Of 246 non-industry interventional studies with no phase under Neuralgia, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 41. This study's 9 months is below that.
Counting every sponsor, half of 264 studies reached it within 24 months; a quarter within 10 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University